Back to search

Article

Cas13b-mediated RNA targeted therapy alleviates genetic dilated cardiomyopathy in mice

2023-06-12

Abstract excerpt

<title>Abstract</title> <p>Background Recent advances in gene editing technology have opened up new avenues for <italic>in vivo</italic> gene therapy, which holds great promise as a potential treatment method for dilated cardiomyopathy (DCM). The CRISPR-Cas13 system has been shown to be an effective tool for knocking down RNA expression in mammalian cells. Results In this study, we delivered PspCas13b with <ita...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2075494a-5c85-596c-a18e-a66e94ee1392
DOI
10.21203/rs.3.rs-2944961/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cas13b-mediated RNA targeted therapy alleviates genetic dilated cardiomyopathy in miceDOI 10.21203/rs.3.rs-2944961/v1
Select a neighboring publication to make it the new centre.